Company Highlights

Supriya Lifescience Limited

Supriya_logo.png

About the Company

Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.
In Fiscal 2021, the company's products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.


Objective of the Issue

(i)   Funding capital expenditure requirements of the company.
(ii)   Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company.
(iii) General corporate purposes.


Business Strategy

(i)   Expansion of manufacturing capabilities.
(ii)  Expanding product portfolio with increasing R&D capabilities.
(iii) Increase current market presence and enter new markets.
(iv) Continue to focus on operational excellence.


Company Promoters

Satish Waman Wagh is the company promoter.



Financials Highlights


Particulars
March 31, 2021 (Rs. in millions)
March 31, 2020 (Rs. in millions)
March 31, 2019 (Rs. in millions)
Income
3,227.13
2,858.62
2,215.10
Expense
2,132.62
2,131.01
1,909.60
Profit After Tax
733.74
394.24
87.28
EPS
10.03
5.39
1.19
RoNW (%)
49.19%
42.03%
15.97%



Issue Details

Issue Size (Net)
upto Rs. 700.00 Cr
Face Value
2 per equity share
Bid Lot
54 Shares
Price Band
Rs. 265 to Rs. 274 per equity share
Issue Opening Date
December 16, 2021
Issue Closing Date
December 20, 2021
Listing On
NSE / BSE
Registrar
Link Intime India Private Ltd


Issue Highlights

Fresh Issue
aggregating up to Rs. 200.00 Cr
Offer For Sale
aggregating up to Rs. 500.00 Cr


IPO Tentative Timetable

IPO Open Date
December 16, 2021
IPO Close Date
December 20, 2021
Basis of Allotment Date
December 23, 2021
Initiation of Refunds
December 24, 2021
Credit of Shares to Demat Account
December 27, 2021
IPO Listing Date
December 28, 2021



Prospectus

Prospectus File

About Us

  • About Us

  • RR Investor Capital Services Pvt. Ltd

    AMFI-registered Mutual Fund Distributor

    Head Office - New Delhi 412-422, Indraprakash Building 21, Barakhamba Road, New Delhi – 01
    Toll Free: 9350316010

Follow Us


  • SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508

  • * Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.




Online